Earlier this month, fellow European drugmaker Roche Holding AG said it was looking into direct sales to bypass players like ...

AstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks Consensus Estimate. Core earnings of $2.17 per share rose 10% year over ...

US stocks pared earlier gains on Tuesday, but kept a bid for more records in sight, as investors combed through a fresh rush ...

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures ...

Stock markets in the United States and Europe rose Tuesday as investors turned their attention from trade deals to a slew of ...

British pharmaceutical giant AstraZeneca on Tuesday said net profit rose 27 percent in the second quarter, boosted by record growth in its key US market.

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the United States. Revenue climbed 12 percent to ...

TACO or tariffs? An August 1 deadline looms after the European Union became the latest of the top US trading partners to ...

The United States and the European Union agreed on a framework trade deal to end months of uncertainty for industries and ...

In European equities on Tuesday, the CAC 40 in Paris gained 0.6%, while the DAX 40 in Frankfurt was up 1.4%. They had ended down 0.4% and 1.0% on Monday.

Astrazeneca has revealed a jump in revenue from cancer drugs amid rumours its boos is eyeing a listing across the pond. Total ...

AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...